Dose- and Organ-Specific Dual Effects of MitoTempo in Paracetamol-Induced Hepatorenal Toxicity in Mice
Biomolecules · 09.04.2026 · 16 (4) · 556
DOI: 10.3390/biom16040556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 09.04.2026. Verfasst von Hilmi Orhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Bornova-İzmir, Türkiye. Hauptthemen laut MEDLINE: Acetaminophen, Organophosphorus Compounds, Kidney, Antioxidants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ege University.
Abstract (Originalsprache)
Paracetamol (PAR) overdose is a major cause of drug-induced liver injury and is also associated with renal toxicity, both involving mitochondrial dysfunction and oxidative stress. This study investigated the dose- and organ-specific effects of the mitochondria-targeted antioxidant MitoTempo (MT) on PAR-induced hepatorenal toxicity in mice. Male C57BL/6J mice received a single toxic dose of PAR (600 mg/kg), either alone or combined with MT (20 or 40 mg/kg). Twenty-four hours after treatment, serum markers of liver and kidney injury were measured, and mitochondrial function was assessed in both organs. PAR administration caused severe liver injury and moderate renal dysfunction, accompanied by increased mitochondrial oxidative stress, glutathione imbalance, mitochondrial permeability transition pore opening, and disruption of electron transport chain (ETC) integrity. MT co-treatment attenuated several PAR-induced mitochondrial alterations in a dose- and tissue-dependent manner; however, MT did not consistently confer protection and, in some settings, exacerbated oxidative stress and bioenergetic dysfunction, particularly in the kidney. Notably, recovery of ETC protein levels by MT was not consistently associated with restoration of enzymatic activity. Overall, these findings demonstrate that MT exerts dual, dose- and organ-specific effects on PAR-induced mitochondrial dysfunction, highlighting that mitochondria-targeted antioxidants are not universally protective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Bornova-İzmir, Türkiye.
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Ege University, 35040 Bornova-İzmir, Türkiye.
ORCID-Profile: Kemal Atmaca
Förderung
- Ege University
Zitieren
APA
Orhan, H., Atmaca, K., Aladağ, B., & Kotmakçı, M. (2026). Dose- and Organ-Specific Dual Effects of MitoTempo in Paracetamol-Induced Hepatorenal Toxicity in Mice. Biomolecules, 16(4), 556. https://doi.org/10.3390/biom16040556
Vancouver
Orhan H, Atmaca K, Aladağ B, Kotmakçı M. Dose- and Organ-Specific Dual Effects of MitoTempo in Paracetamol-Induced Hepatorenal Toxicity in Mice. Biomolecules. 2026;16(4):556. doi:10.3390/biom16040556
BibTeX
@article{Orhan2026,
author = {Orhan, Hilmi and Atmaca, Kemal and Aladağ, Berin and Kotmakçı, Mustafa},
title = {Dose- and Organ-Specific Dual Effects of MitoTempo in Paracetamol-Induced Hepatorenal Toxicity in Mice},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {4},
pages = {556},
doi = {10.3390/biom16040556}
}
EUVIMED